Does TRABECTEDIN Cause Neoplasm progression? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Neoplasm progression have been filed in association with TRABECTEDIN (YONDELIS). This represents 1.0% of all adverse event reports for TRABECTEDIN.
19
Reports of Neoplasm progression with TRABECTEDIN
1.0%
of all TRABECTEDIN reports
9
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm progression From TRABECTEDIN?
Of the 19 reports, 9 (47.4%) resulted in death, 5 (26.3%) required hospitalization, and 3 (15.8%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRABECTEDIN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does TRABECTEDIN Cause?
Neutropenia (207)
Anaemia (189)
Thrombocytopenia (172)
Nausea (160)
Febrile neutropenia (142)
Pancytopenia (124)
Vomiting (121)
Rhabdomyolysis (117)
Off label use (105)
Alanine aminotransferase increased (104)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TRABECTEDIN Alternatives Have Lower Neoplasm progression Risk?
TRABECTEDIN vs TRACLEER
TRABECTEDIN vs TRADJENTA
TRABECTEDIN vs TRALOKINUMAB-LDRM
TRABECTEDIN vs TRAMADOL
TRABECTEDIN vs TRAMADOL\TRAMADOL